Skip to content
Clinical Trials – home

Penile cancer Diagnostics

3 / 5 trials open to patients4 countries

In short

Finding out you have penile cancer can feel overwhelming, but understanding how it gets diagnosed is an important first step. Getting the right tests done early can make a huge difference in treatment success, and knowing what to expect can help ease some of the worry that comes with seeking medical care.

Key points

  • Up to half of men with penile cancer wait a year before seeking medical help, which significantly worsens survival chances and treatment outcomes.
  • A biopsy is the only definitive way to diagnose penile cancer—many harmless conditions look identical to cancer on the surface.
  • Penile cancer caught at early stages (0, I, or II) is highly curable, but survival drops sharply once it reaches stage III or IV.
  • Any painless lump, sore that won't heal, or unusual discharge on your penis warrants an immediate doctor's visit, even if it doesn't hurt.
  • About 80% of penile cancer cases occur in men over age 55, making regular self-checks increasingly important as you age.
  • CT scans of the chest, abdomen, and pelvis help doctors determine if cancer has spread to lymph nodes or distant organs.
  • Clinical trials for penile cancer require extensive diagnostic testing including confirmed biopsy results, detailed imaging, and blood work to assess organ function.
  • About a quarter of penile cancers are initially misdiagnosed, highlighting the importance of seeing specialists experienced with this rare disease.

Introduction: Who Should Get Checked for Penile Cancer

If you notice any unusual changes on your penis, it's important to see a healthcare provider as soon as possible. Many men delay getting checked because they feel embarrassed, scared, or hope the problem will go away on its own. This delay can be dangerous because penile cancer is much easier to treat when caught early.

You should seek medical attention if you notice a lump or sore on your penis that doesn't heal, especially if it's painless. Other warning signs include skin changes such as discoloration, thickening, or crusty bumps on the penis. Redness, irritation, or unusual swelling on the head of your penis should also prompt a visit to your doctor. If you notice foul-smelling fluid underneath your foreskin, bleeding, or discharge, these are additional reasons to get examined right away.

Keep in mind that less serious conditions like infections or allergic reactions can cause similar symptoms. However, it's always better to have a healthcare provider examine you rather than assume it's nothing serious. When penile cancer is found early, it can often be cured, but cancer that has spread to other parts of the body becomes much harder to treat.

Men over age 55 should be especially alert to changes in their penis, as about 80% of penile cancer cases in the United States occur in this age group. If you're uncircumcised, have a condition called phimosis (where the foreskin can't be pulled back over the head of the penis), have been infected with human papillomavirus (HPV), or smoke, you're at higher risk and should be even more vigilant about checking yourself and seeking care when something seems wrong.

Diagnostic Methods for Identifying Penile Cancer

When you visit a healthcare provider with concerns about penile cancer, they will start with some basic steps to understand what's happening. The diagnostic process typically involves several different types of examinations and tests to confirm whether cancer is present and, if so, what type it is.

Physical Examination and Medical History

Your doctor will begin by asking about your symptoms and health history. They'll want to know when you first noticed the changes, whether you've had any pain or bleeding, and details about your past illnesses and treatments. This conversation helps them understand your overall health and identify any risk factors you might have.

Next comes a physical exam where the doctor carefully examines your penis, looking for any lumps, sores, discoloration, or other unusual signs. They'll check for anything that seems abnormal, including the size and location of any growths. This examination also includes feeling for swollen lymph nodes in your groin area, since penile cancer can spread to these small bean-shaped structures that are part of your body's infection-fighting system.

Biopsy: The Definitive Test

A biopsy is the most important test for diagnosing penile cancer because it's the only way to know for certain whether you have cancer. During a biopsy, the doctor removes a small sample of tissue from the suspicious area so it can be examined under a microscope by a specialist called a pathologist. The pathologist looks for cancer cells and can determine exactly what type of cancer is present.

There are different types of biopsies your doctor might perform. An incisional biopsy removes just part of a lump or abnormal tissue. This is often used when the growth is large. An excisional biopsy removes the entire lump or abnormal area. This approach is more common when the lesion is small, and your doctor may try to remove it completely along with a surrounding layer of normal tissue. Depending on the situation, a circumcision might be performed at the same time, especially if the cancer is on the foreskin.

Many non-cancerous (benign) lesions on the penis can look similar to cancer, which is why the biopsy is so critical. It's the only way to tell the difference between something harmless and something that needs treatment.

Imaging Tests to See Inside Your Body

If cancer is confirmed through biopsy, your doctor will likely order imaging tests to determine whether the cancer has spread beyond the penis. These tests create detailed pictures of the inside of your body and help doctors understand the full extent of the disease.

A CT scan (computed tomography scan) uses X-rays and a computer to create three-dimensional images of your body. For penile cancer, doctors typically order CT scans of your chest, abdomen, and pelvis to check whether cancer has spread to lymph nodes in the groin or pelvis, or to distant organs. These scans help doctors see things that can't be detected during a physical exam.

An MRI scan (magnetic resonance imaging) uses powerful magnets and radio waves instead of X-rays to create detailed images. MRI scans are particularly good at showing soft tissue and can help doctors see how deeply cancer has invaded into the structures of the penis.

A bone scan might be ordered if your doctor suspects the cancer may have spread to your bones. This test involves injecting a small amount of radioactive material into a vein, which then collects in areas where bone is abnormal. Special cameras detect this radioactivity and create images showing any problem areas.

Penile cancer most often spreads first to the lymph nodes in the groin and then to lymph nodes in the pelvis before traveling to other parts of the body. Understanding this pattern of spread helps doctors determine which imaging tests are most important for staging your cancer.

Diagnostic Tests for Clinical Trial Qualification

If you're considering participating in a clinical trial for penile cancer, you'll need to undergo specific diagnostic tests to determine whether you qualify. Clinical trials have strict requirements about who can participate, and these requirements exist to ensure patient safety and to make the study results reliable.

Standard Qualification Testing

Before enrolling in a clinical trial, researchers need to confirm your exact diagnosis and understand the stage of your cancer. This typically requires having a confirmed tissue diagnosis through biopsy, which proves you have penile cancer and identifies the specific type. The pathology report from your biopsy becomes a crucial document for trial enrollment.

Clinical trials also require detailed information about how far your cancer has spread. This means you'll need comprehensive imaging studies, usually including CT scans of your chest, abdomen, and pelvis. These scans help determine your cancer stage, which is often a key factor in deciding which trials you're eligible for. Some trials only accept patients with early-stage disease, while others focus on advanced or metastatic cancer (cancer that has spread to distant parts of the body).

Blood tests are another standard requirement for clinical trial qualification. These tests measure your overall health and how well your organs are functioning. Researchers need to know that your kidneys, liver, and bone marrow are working well enough to handle the experimental treatment being studied. Blood tests also establish a baseline for comparison, so doctors can track how the treatment affects your body over time.

Additional Assessments

Depending on the specific clinical trial, you might need additional diagnostic procedures. Some trials require testing of your tumor tissue for specific genetic markers or proteins that might predict how you'll respond to the experimental treatment. This is especially common in trials testing targeted therapies or immunotherapies.

Your overall physical condition, often measured using standardized scales, is another important qualification factor. Doctors assess whether you're strong enough to participate in the trial and handle potential side effects. This assessment involves a thorough physical examination and review of your medical history, including any other health conditions you have.

The diagnostic requirements for clinical trials are more extensive than those for standard care because researchers need very detailed information to properly evaluate the experimental treatment. While this means more tests, participating in a trial may give you access to promising new therapies that aren't yet widely available.

Prognosis and Survival Rate

Prognosis

The prognosis for penile cancer depends on several important factors. When penile cancer is diagnosed early, at stage 0, stage I, or stage II, it is highly curable. Treatment during these early stages can often completely eliminate the cancer, allowing men to recover fully. However, the outlook becomes much less favorable when cancer reaches stage III or stage IV, meaning it has spread to lymph nodes or distant parts of the body.

The size and location of your tumor affect how the disease progresses. Smaller tumors that haven't grown deeply into the tissues of the penis respond better to treatment than larger ones. How invasive the cancer is also matters—cancer that has grown into blood vessels, nerves, or deeper structures is more likely to spread and harder to treat successfully.

Whether cancer has spread to lymph nodes is one of the most important factors affecting prognosis. Penile cancer typically spreads first to lymph nodes in the groin, then to lymph nodes in the pelvis, before traveling to distant organs. The more lymph nodes involved and the further the cancer has spread, the more challenging treatment becomes.

Your overall health at the time of diagnosis also influences your outlook. Men who are otherwise healthy, don't smoke, and maintain good immune function tend to respond better to treatment. The specific type of penile cancer you have matters too—some forms grow more aggressively than others.

Survival Rate

Survival rates for penile cancer vary dramatically based on the stage at diagnosis. When found and treated early, penile cancer can often be cured, and many men survive long-term. However, specific survival statistics depend heavily on whether the cancer was caught before it spread.

Early-stage penile cancer that hasn't spread beyond the penis has the best survival outlook. In these cases, treatment in the early stages can keep the cancer from growing and spreading to other areas. The curability decreases sharply once cancer reaches stage III or IV, when it has spread to lymph nodes or distant parts of the body.

The delay many men experience before seeking medical care significantly impacts survival rates. When men wait months or even a year before seeing a doctor, the cancer has more time to grow and spread, making it much harder to treat successfully. This is why early detection is absolutely crucial for improving survival chances.

Did you know?

  1. About 25% of penile cancer cases are initially misdiagnosed by clinicians, contributing to treatment delays that affect patient outcomes.[6]
  2. Penile cancer makes up less than 1% of all cancers in men in the United States, making it rarer than most people realize, though it's more common in parts of Africa, Asia, and South America.[1][11]
  3. Many benign lesions of the penis look identical to cancer, which is why a biopsy examined under a microscope is the only definitive way to make the diagnosis.[3]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Penile cancer

Recruiting trials first

See all 5 trials →
Quick filters

5 clinical trials in this condition

Renal cancer+2

Recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Ac-Ala-Gly-Ser-Cys(1)-Tyr-Cys(2)-Ser-Gly-Pro-Pro-Arg-Phe-Glu-Cys(2)-Trp-Cys(1)-Tyr-Glu-Thr-Glu-Gly-Thr-Gly-Gly-Gly-Lys(Unk)-Nh2 Conjugated To Cy5 Dye
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Unicancer

Penile cancer

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Anal cancer+5

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Transgene
See all 5 trials →filters applied: condition = Penile cancer

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).